Researchers have succeeded in mitigating chronic inflammation in mice using customized 'mini-antibodies.' These nanobodies enabled them to dissolve molecular complexes in tissue that normally activate the immune system. The nanobodies produced may in future help to slow down unwanted inflammatory reactions that cause diseases such as arthritis or neurodegeneration.
